PARIS, June 25 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 ...
Would you please explain how to convert 70/30 insulin coverage to Lantus coverage? When our patients are admitted to the hospital, they are usually converted to Lantus with a sliding scale. Patient AB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results